Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?

Maarten E Tushuizen1, Michaela Diamant, Augueste Sturk

  • 1Department of Clinical Chemistry, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. r.nieuwland@amc.uva.nl

Insights

Microparticles play dual roles in cardiovascular health, contributing to disease development and also aiding in cellular balance and defense mechanisms. Understanding these complex functions is key to managing cardiovascular conditions.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Hemostasis

Background:

  • Microparticles are implicated in critical physiological processes like coagulation, inflammation, and endothelial function.
  • Dysregulation of these processes is linked to atherosclerosis and cardiovascular disease.
  • Traditionally viewed as detrimental, microparticles' roles are now understood to be more complex.

Purpose of the Study:

  • To review recent research on the multifaceted roles of microparticles in cardiovascular disease.
  • To explore both the detrimental and beneficial functions of microparticles.
  • To provide a comprehensive overview of microparticle involvement in cardiovascular health and disease.

Main Methods:

  • Literature review of recent studies on microparticles.
  • Analysis of research investigating microparticle functions in cardiovascular contexts.
  • Synthesis of findings on microparticle roles in coagulation, inflammation, endothelial function, homeostasis, and defense.

Main Results:

  • Microparticles contribute to the pathogenesis of atherosclerosis and cardiovascular disease through roles in coagulation and inflammation.
  • Emerging evidence highlights microparticles' involvement in maintaining cellular homeostasis.
  • Microparticles also play a role in promoting organismal defense mechanisms.

Conclusions:

  • Microparticles exhibit a dual nature in cardiovascular disease, with both harmful and protective functions.
  • Further research is needed to fully elucidate the complex roles of microparticles.
  • Targeting microparticle functions may offer novel therapeutic strategies for cardiovascular disease.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Inflammation01:38

Inflammation

Overview